Alison Campbell, FNP-C - Medicare Nurse Practitioner in Grenada, MS

Alison Campbell, FNP-C is a medicare enrolled "Nurse Practitioner - Family" in Grenada, Mississippi. She graduated from nursing school in 2020 and has 4 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Tallahatchie General Hospital and her current practice location is 1117 Sunset Dr Ste 104, Grenada, Mississippi. You can reach out to her office (for appointments etc.) via phone at (662) 226-0110.

Alison Campbell is licensed to practice in Mississippi (license number 904147) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1205441375.

Contact Information

Alison Campbell, FNP-C
1117 Sunset Dr Ste 104,
Grenada, MS 38901-4080
(662) 226-0110
Not Available



Provider's Profile

Full NameAlison Campbell
GenderFemale
SpecialityNurse Practitioner
Experience4 Years
Location1117 Sunset Dr Ste 104, Grenada, Mississippi
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Alison Campbell graduated from nursing school in 2020
  NPI Data:
  • NPI Number: 1205441375
  • Provider Enumeration Date: 09/15/2020
  • Last Update Date: 09/15/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1355753195
  • Enrollment ID: I20201218001420

Medical Identifiers

Medical identifiers for Alison Campbell such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205441375NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family 904147 (Mississippi)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Tallahatchie Critical Access HospitalCharleston, MSHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Tallahatchie General Hospital105220809717

News Archive

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)].

Anticancer drug may reduce mortality and speed up recovery for severe COVID-19 patients

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020.

Interactive campaign to raise awareness on breast cancer

This week, Yoplait, in partnership with Susan G. Komen for the Cure, launched Know Your Girls, an interactive campaign that empowers young women to learn about breast cancer risk factors - and then share this knowledge with their circle of friends.

Metabolism drives the brain clock, reveals study

The rhythm of life is driven by the cycles of day and night, and most organisms carry in their cells a common, (roughly) 24-hour beat. In animals, this rhythm emerges from a tiny brain structure called the suprachiasmatic nucleus (SCN) in the hypothalamus. Take it out of the brain and keep it alive in a lab dish and this "brain clock" will keep on ticking, ramping up or gearing down production of certain proteins at specific times of the day, day after day.

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Alison Campbell allows following entities to bill medicare on her behalf.
Entity NameTallahatchie General Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1679733497
PECOS PAC ID: 1052208097
Enrollment ID: O20040303000646

News Archive

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)].

Anticancer drug may reduce mortality and speed up recovery for severe COVID-19 patients

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020.

Interactive campaign to raise awareness on breast cancer

This week, Yoplait, in partnership with Susan G. Komen for the Cure, launched Know Your Girls, an interactive campaign that empowers young women to learn about breast cancer risk factors - and then share this knowledge with their circle of friends.

Metabolism drives the brain clock, reveals study

The rhythm of life is driven by the cycles of day and night, and most organisms carry in their cells a common, (roughly) 24-hour beat. In animals, this rhythm emerges from a tiny brain structure called the suprachiasmatic nucleus (SCN) in the hypothalamus. Take it out of the brain and keep it alive in a lab dish and this "brain clock" will keep on ticking, ramping up or gearing down production of certain proteins at specific times of the day, day after day.

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alison Campbell is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Alison Campbell, FNP-C
2671 Perry Rd,
Grenada, MS 38901-9067

Ph: (662) 809-4315
Alison Campbell, FNP-C
1117 Sunset Dr Ste 104,
Grenada, MS 38901-4080

Ph: (662) 226-0110

News Archive

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)].

Anticancer drug may reduce mortality and speed up recovery for severe COVID-19 patients

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020.

Interactive campaign to raise awareness on breast cancer

This week, Yoplait, in partnership with Susan G. Komen for the Cure, launched Know Your Girls, an interactive campaign that empowers young women to learn about breast cancer risk factors - and then share this knowledge with their circle of friends.

Metabolism drives the brain clock, reveals study

The rhythm of life is driven by the cycles of day and night, and most organisms carry in their cells a common, (roughly) 24-hour beat. In animals, this rhythm emerges from a tiny brain structure called the suprachiasmatic nucleus (SCN) in the hypothalamus. Take it out of the brain and keep it alive in a lab dish and this "brain clock" will keep on ticking, ramping up or gearing down production of certain proteins at specific times of the day, day after day.

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells.

Read more News

› Verified 5 days ago


Nurse Practitioner Nurses in Grenada, MS

Kelsey Marter Faulkner,
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 965 Avent Dr, Grenada, MS 38901
Phone: 601-815-2005    
Mrs. Agnes Pamela Upchurch, FNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1350 Sunset Dr, Ste B, Grenada, MS 38901
Phone: 662-229-0669    Fax: 662-227-9929
Courtney Bullard, AGNP-C
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1966 F S Hill Dr, Grenada, MS 38901
Phone: 662-688-1519    
Mrs. Ashley Nicole Woods, FNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 140 Broadfield Dr, Grenada, MS 38901
Phone: 662-809-2419    
Latia Monanette Butts, CFNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1300 Sunset Dr, Ste Q, Grenada, MS 38901
Phone: 662-349-2442    Fax: 662-349-8551
Shonda Jacqueline Phelon, C.F.N.P.; P.M.H.N.P
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1970 Grandview Dr, Grenada, MS 38901
Phone: 662-227-3700    Fax: 662-227-3740

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.